Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Gerson

Showing results (141-150 of 257) with videos related to

Pageof 26
Sort By:
The American Journal of Medicine|July 1, 1985
Discriminant scorecard for diagnosis of invasive pulmonary aspergillosis in patients with acute leukemiaS L Gerson, G H Talbot, S Hurwitz, et al.
Carcinogenesis|March 1, 1995
Transgenic expression of human MGMT protects against azoxymethane-induced aberrant crypt foci and G to A mutations in the K-ras oncogene of mouse colonN H Zaidi, T P Pretlow, M A O'Riordan, et al.
Virus Research|December 6, 2014
MGMT enrichment and second gene co-expression in hematopoietic progenitor cells using separate or dual-gene lentiviral vectorsJustin C Roth, Michael O Alberti, Mourad Ismail, et al.
Cancer Research|November 26, 1997
Selection for G156A O6-methylguanine DNA methyltransferase gene-transduced hematopoietic progenitors and protection from lethality in mice treated with O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosoureaB M Davis, J S Reese, O N Koç, et al.
Human Gene Therapy|December 10, 1999
Characterization of the P140K, PVP(138-140)MLK, and G156A O6-methylguanine-DNA methyltransferase mutants: implications for drug resistance gene therapyB M Davis, J C Roth, L Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2005
Phase II trial of the O6-alkylguanine DNA alkyltransferase inhibitor O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea in advanced melanomaThomas F Gajewski, Jeffrey Sosman, Stanton L Gerson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1995
Modulation of O6-alkylguanine alkyltransferase-directed DNA repair in metastatic colon cancersJ K Willson, J R Haaga, J E Trey, et al.
Radiology|December 1, 1985
Invasive pulmonary aspergillosis and acute leukemia. Limitations in the diagnostic utility of the air crescent signW B Gefter, S M Albelda, G H Talbot, et al.
Cancer Research|July 1, 1986
Differential effects of phorbol esters on normal myeloid precursors and leukemic cells: basis for autologous bone marrow reconstitution in acute nonlymphocytic leukemia using phorbol ester-treated bone marrow from patients in remissionJ L Abrahm, S L Gerson, J A Hoxie, et al.
Annual Review of Medicine|January 31, 2002
Cancer gene therapy: scientific basisPunit D Wadhwa, Steven P Zielske, Justin C Roth, et al.
Pageof 26

Showing results (141-150 of 257) with videos related to

Sort By:
Pageof 26
The American Journal of Medicine|July 1, 1985
Discriminant scorecard for diagnosis of invasive pulmonary aspergillosis in patients with acute leukemiaS L Gerson, G H Talbot, S Hurwitz, et al.
Carcinogenesis|March 1, 1995
Transgenic expression of human MGMT protects against azoxymethane-induced aberrant crypt foci and G to A mutations in the K-ras oncogene of mouse colonN H Zaidi, T P Pretlow, M A O'Riordan, et al.
Virus Research|December 6, 2014
MGMT enrichment and second gene co-expression in hematopoietic progenitor cells using separate or dual-gene lentiviral vectorsJustin C Roth, Michael O Alberti, Mourad Ismail, et al.
Cancer Research|November 26, 1997
Selection for G156A O6-methylguanine DNA methyltransferase gene-transduced hematopoietic progenitors and protection from lethality in mice treated with O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosoureaB M Davis, J S Reese, O N Koç, et al.
Human Gene Therapy|December 10, 1999
Characterization of the P140K, PVP(138-140)MLK, and G156A O6-methylguanine-DNA methyltransferase mutants: implications for drug resistance gene therapyB M Davis, J C Roth, L Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2005
Phase II trial of the O6-alkylguanine DNA alkyltransferase inhibitor O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea in advanced melanomaThomas F Gajewski, Jeffrey Sosman, Stanton L Gerson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1995
Modulation of O6-alkylguanine alkyltransferase-directed DNA repair in metastatic colon cancersJ K Willson, J R Haaga, J E Trey, et al.
Radiology|December 1, 1985
Invasive pulmonary aspergillosis and acute leukemia. Limitations in the diagnostic utility of the air crescent signW B Gefter, S M Albelda, G H Talbot, et al.
Cancer Research|July 1, 1986
Differential effects of phorbol esters on normal myeloid precursors and leukemic cells: basis for autologous bone marrow reconstitution in acute nonlymphocytic leukemia using phorbol ester-treated bone marrow from patients in remissionJ L Abrahm, S L Gerson, J A Hoxie, et al.
Annual Review of Medicine|January 31, 2002
Cancer gene therapy: scientific basisPunit D Wadhwa, Steven P Zielske, Justin C Roth, et al.
Pageof 26